The NCRI Children’s Group has six subgroups that develop research in areas of strategic need.

The Central Nervous System (CNS) Subgroup, chaired by Professor Simon Bailey, develops research into cancer of the central nervous system in children.

Members:

Simon Bailey, Professor of Paediatric Neuro-Oncology and Consultant Paediatric Oncologist, Royal Victoria Infirmary

Jenny Adamski, University Hospitals Birmingham NHS Foundation Trust

Kim Bull, Senior Research Fellow, University of Southampton
Steve Clifford, Professor of Molecular Paediatric Oncology, Newcastle University

Julia Cockle, Clinical Research Fellow Paediatrics, University of Leeds

Richard Grundy, Professor of Paediatric Neuro-oncology and Cancer Biology, University of Nottingham

Darren Hargrave, Co-Chair of the London Cancer Children and Young Person’s Specialist Board, Great Ormond Street Hospital for Children NHS Foundation Trust

Tom Jacques, Reader in Paediatric Neuropathology, University College London (UCL)

Conor Mallucci, Consultant Paediatric Neurosurgeon, Alder Hey Children’s NHS Foundation Trust

Andrew Peet, Professor of Clinical Paediatric Oncology, King’s College London (KCL)

Sue Picton, Consultant Paediatric Oncologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Barry Pizer, Consultant Paediatric Oncologist, Alder Hey Children’s NHS Foundation Trust

Nicky Thorp, Consultant in Clinical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust

The Germ Cell Tumour (GCT) Subgroup, chaired by Dr Sara Stoneham, develops research into cancer of germ cells, which form from reproductive cells such as the testicles (testicular cancer) or the ovaries (ovarian cancer).

Members:

Thankamma Ajithkumar, Consultant Clinical Oncologist, Cambridge University Hospitals NHS Foundation Trust

Suren Arul, Consultant Paediatric Surgeon, Birmingham Women’s and Children’s NHS Foundation Trust

Mark Brougham, Consultant Paediatric Oncologist, Royal Hospital for Sick Children

Dr Alex Freeman, , University College London Hospitals NHS Foundation Trust (UCLH)

James Hayden, Consultant Paediatric Oncologist, Alder Hey Children’s NHS Foundation Trust

Matthew Murray, Consultant, University of Cambridge

James Nicholson, Consultant Paediatric Oncologist, Cambridge University Hospitals NHS Foundation Trust

Anthony Penn, Consultant Paediatric Oncologist, Manchester University Hospitals NHS Foundation Trust

Amy Ruffle, Paediatric Oncology Registrar, Addenbrooke’s Hospital NHS Foundation Trust

Dan Stark, Professor, Consultant Medical Oncologist – Teenagers and Young Adults with Cancer, Testicular cancer, Sarcomas of Soft Tissue and, University of Leeds
Shaun Wilson, Consultant Paediatric Oncologist, Oxford University Hospitals NHS Foundation Trust

The Leukaemia Subgroup, chaired by Dr Phil Ancliff, develops research into cancer of the body’s blood-forming tissues, including the bone marrow and the lymphatic system, in children.

Members:

Phil Ancliff, Consultant Haematologist, Great Ormond Street Hospital for Children NHS Foundation Trust (subgroup chair)

Denise Bonney, Consultant Paediatric Haematologist, Manchester University Hospitals NHS Foundation Trust

Michelle Cummins, Consultant in Paediatric Haematology and Bone Marrow Transplantation, University Hospitals Bristol NHS Foundation Trust

Brenda Gibson, Royal Hospital For Children (NHSGGC)

Rachael Hough, University College London Hospitals NHS Foundation Trust (UCLH)

Donna Lancaster, Consultant Paediatric Oncologist, Royal Marsden NHS Foundation Trust

Anthony Moorman, Professor of Genetic Epidemiolgy, Newcastle University

John Moppett, Consultant Paediatric Haematologist, University Hospitals Bristol NHS Foundation Trust

Neil Ranasinghe, No affiliation

Anupama Rao, Consultant in Paediatric Haematology, Great Ormond Street Hospital for Children NHS Foundation Trust

Clare Rowntree, Cardiff and Vale University Health Board (CVUHB)

Sujith Samarasinghe, Great Ormond Street Hospital for Children NHS Foundation Trust

Owen Smith, Consultant Paediatric Haematologist, Children’s Health Ireland at Crumlin

Josef Vormoor, Consultant in Paediatric Oncology, Royal Victoria Infirmary

The Neuroblastoma Subgroup, chaired by Dr Juliet Gray, develops research into cancer that develops from specialised nerve cells called neuroblasts that mostly affects babies and young children.

Members:

Juliet Gray, Consultant in Paediatric Oncology, University Hospital Southampton NHS Foundation Trust (subgroup chair)

John Anderson, Professor of Experimental Paediatric Oncology, University College London Hospitals NHS Foundation Trust (UCLH)

Guiseppe Barone, Consultant in Paediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust

Nicholas Bird

Susan Burchill, Consultant, University of Leeds

Louis Chesler, Institute of Cancer Research (ICR)

Martin Elliott, Consultant Paediatric Oncologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Ben Fulton, Clinical Oncologist, NHS Greater Glasgow and Clyde

Hany Gabra, Consultant Paediatric Surgeon, Royal Victoria Infirmary

Mark N Gaze, Consultant in Clinical Oncology, University College London Hospitals NHS Foundation Trust (UCLH)

Guy Makin, Senior Lecturer in Paediatric Oncology, University of Manchester

Andrew Pearson, Retired Consultant Paediatric Oncologist, No affiliation

Ramya Ramanujachar, Consultant Paediatric Oncologist, University Hospital Southampton NHS Foundation Trust

Deborah Tweddle, Professor of Paediatric Oncology and Honorary Consultant in Paediatric & Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust

Simon Wan, Radionuclide Radiologist, University College London Hospitals NHS Foundation Trust (UCLH)

Keith Wheatley, Scientific Director, Birmingham Cancer Research UK Clinical Trials Unit (CRCTU), King’s College London (KCL)

Kate Wheeler, Consultant Paediatric Oncologist, Oxford University Hospitals NHS Foundation Trust

The Novel Agents Subgroup, chaired by Dr Lynley Marshall, develops research into innovative products that serve unmet needs in childhood cancer or significantly help to advance childhood cancer care.

Members:

Lynley Marshall, Consultant in Paediatric Drug Development, Institute of Cancer Research (ICR) (subgroup chair)

Charlotte Burns, Paediatric Oncology Registrar, Great Ormond Street Hospital for Children NHS Foundation Trust

Steve Clifford, Professor of Molecular Paediatric Oncology, Newcastle University

Martin Elliott, Consultant Paediatric Oncologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Pamela Kearns, Director, Birmingham Cancer Research UK Clinical Trials Unit (CRCTU), King’s College London (KCL)

Guy Makin, Senior Lecturer in Paediatric Oncology, University of Manchester

Bruce Morland, Professor, Birmingham Women’s and Children’s NHS Foundation Trust

Andrew Peet, Professor of Clinical Paediatric Oncology, King’s College London (KCL)

Gareth Veal, Newcastle University

Ajay Vora, Great Ormond Street Hospital for Children NHS Foundation Trust

Josef Vormoor, Consultant in Paediatric Oncology, Royal Victoria Infirmary

The Paediatric Non-Hodgkin Lymphoma Subgroup, chaired by Dr Mary Taj, develops research into non-Hodgkin lymphoma in children.

Members:

Mary Taj, Institute of Cancer Research (ICR) (subgroup chair)

Simon Bomken, Newcastle University

Ben Carpenter, TYA and Adult Consultant Haematologist, University College London Hospitals NHS Foundation Trust (UCLH)

Andrew Davies, Associate Professor And Consultant In Medical Oncology, University Hospital Southampton NHS Foundation Trust – Princess Anne Hospital

Stephen Daw, University College London Hospitals NHS Foundation Trust (UCLH)

Rebecca Ling, King’s College London (KCL)

Andrew Raxworthy-Cooper, King’s College London (KCL)

Emma Seaford, King’s College London (KCL)

Owen Smith, Consultant Paediatric Haematologist, Children’s Health Ireland at Crumlin

Suzanne Turner, University of Cambridge

Keith Wheatley, Scientific Director, Birmingham Cancer Research UK Clinical Trials Unit (CRCTU), King’s College London (KCL)

Andrew Wotherspoon, Consultant Histopathologist, Royal Marsden NHS Foundation Trust

Robert Wynn, Manchester University Hospitals NHS Foundation Trust